<?xml version="1.0" encoding="UTF-8"?>
<p>A linear PK trend was seen with a single dose of 3 to 225 mg intravenous remdesivir infusion for 2 hours. However, active substance accumulated in vivo in daily administration schedule. Therefore, a maintenance dose of 100 mg is advised after a loading dose of 200 mg to maintain appropriate blood concentration in vivo.
 <sup>
  <xref rid="B6" ref-type="bibr">6</xref>
 </sup> As of June 2020, Phase I trials with remdesivir have demonstrated adequate safety, tolerability following intravenous use without any serious adverse effects or liver toxicity.
</p>
